KERLINE LAHENS-HEADLEY: Open Payments
NPI 1780453084 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $369 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $117 |
Products named: KRYSTEXXA, CAPLYTA, Auvelity, COBENFY, ENTYVIO.
Industry payments across NY — which companies pay providers there.
